Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 10, Number 2, February 1999   [Index by Author] 
Other Issues: Previous Next  

Down News
Down Book reviews
Down Editorials
Down Review
Down Commentary
Down Arena
Down Original articles
Down Clinical case
Down Short reports
Down Letters to the editor


[Search ALL Issues]


Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

News Back

Not much new in Miami
Ann Oncol 1999 10: 129. [PDF] [Request Permissions]  

Paul Marks to retire
Ann Oncol 1999 10: 129-130. [PDF] [Request Permissions]  

UK White Paper on tobacco
Ann Oncol 1999 10: 130. [PDF] [Request Permissions]  

Alternative medicine and prostate cancer on the winning side
Ann Oncol 1999 10: 130-131. [PDF] [Request Permissions]  

More private medicine in Italian oncology hospitals
Ann Oncol 1999 10: 131. [PDF] [Request Permissions]  

Perhaps not everyone knows that...
Ann Oncol 1999 10: 131-133. [PDF] [Request Permissions]  

Book reviews Back

H. Neuenschwander
Book review
Ann Oncol 1999 10: 134. [PDF] [Request Permissions]  

Editorials Back

I.J. Higginson and P. Edmonds
Services, costs and appropriate outcomes in end of life care
Ann Oncol 1999 10: 135-136. [PDF] [Request Permissions]  

G. Masera and A. Biondi
Research in low-income countries
Ann Oncol 1999 10: 137-138. [PDF] [Request Permissions]  

Review Back

W. M. Gallagher and R. Brown
p53-Oriented cancer therapies: Current progress
Ann Oncol 1999 10: 139-150. [Abstract] [PDF] [Request Permissions]  

Commentary Back

A. Santoro
Advanced soft tissue sarcoma: How many more trials with anthracyclines and ifosfamide?
Ann Oncol 1999 10: 151-154. [PDF] [Request Permissions]  

Arena Back

S. A. Luykx-de Bakker, H. M. W. Verheul, T. D. de Gruijl, and H. M. Pinedo
Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations
Ann Oncol 1999 10: 155-160. [Abstract] [PDF] [Request Permissions]  

Original articles Back

P. O. Witteveen, M. A. C. van Groenestijn, G. H. Blijham, and A. J. P. Schrijvers
Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer
Ann Oncol 1999 10: 161-165. [Abstract] [PDF] [Request Permissions]  

S. Advani, S. Pai, D. Venzon, M. Adde, P. K. Kurkure, C. N. Nair, B. Sirohi, S. D. Banavali, R. Hawaldar, B. B. Kolhatkar, T. Vats, and I. Magrath
Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen
Ann Oncol 1999 10: 167-176. [Abstract] [PDF] [Request Permissions]  

C. L. Bennett, T. J. Stinson, M. S. Tallman, E. A. Stadtmauer, R. W. Marsh, W. Friedenberg, H. M. Lazarus, L. Kaminer, R. M. Golub, J. M. Rowe, and the Eastern Cooperative Oncology Group (E1490)
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia
Ann Oncol 1999 10: 177-182. [Abstract] [PDF] [Request Permissions]  

M. J. Rummel, G. Käfer, M. Pfreundschuh, E. Jäger, U. Reinhardt, P. S. Mitrou, D. Hoelzer, and L. Bergmann
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study
Ann Oncol 1999 10: 183-188. [Abstract] [PDF] [Request Permissions]  

D. Errante, J. Gabarre, A. L. Ridolfo, G. Rossi, A. M. Nosari, C. Gisselbrecht, Y. Kerneis, F. Mazzetti, E. Vaccher, R. Talamini, A. Carbone, and U. Tirelli
Hodgkin's disease in 35 patients with HIV infection: An experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF
Ann Oncol 1999 10: 189-195. [Abstract] [PDF] [Request Permissions]  

J. Norum
Breast cancer screening by mammography in Norway. Is it cost-effective?
Ann Oncol 1999 10: 197-203. [Abstract] [PDF] [Request Permissions]  

M. E. R. O'Brien, R. C. Leonard, P. J. Barrett-Lee, S. P. H. Eggleton, J.-P. Bizzari, and UK Study Group
Docetaxel in the community setting: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere®) in the UK
Ann Oncol 1999 10: 205-210. [Abstract] [PDF] [Request Permissions]  

D. Mavroudis, N. Malamos, A. Alexopoulos, Ch. Kourousis, S. Agelaki, E. Sarra, A. Potamianou, Ch. Kosmas, G. Rigatos, Th. Giannakakis, K. Kalbakis, F. Apostolaki, J. Vlachonicolis, S. Kakolyris, G. Samonis, V. Georgoulias, and Greek Breast Cancer Cooperative Group
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
Ann Oncol 1999 10: 211-215. [Abstract] [PDF] [Request Permissions]  

P. Lippe, D. Tummarello, M. C. Monterubbianesi, R. R. Silva, L. Giuliodori, D. Mari, A. Santo, F. Pasini, G. L. Cetto, D. Rossi, E. Porfiri, S. Cascinu, and R. Cellerino
Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase II study
Ann Oncol 1999 10: 217-221. [Abstract] [PDF] [Request Permissions]  

T. Petit, C. Aylesworth, H. Burris, P. Ravdin, G. Rodriguez, L. Smith, N. Peacock, L. Smetzer, R. Bellet, D. D. Von Hoff, and E. K. Rowinsky
A phase I study of docetaxel and 5-fluorouraciI in patients with advanced solid malignancies
Ann Oncol 1999 10: 223-229. [Abstract] [PDF] [Request Permissions]  

Clinical case Back

M. Mitterer, N. Pescosta, C Mc Quain, U. Gebert, F. Oberkofler, P. Coser, and H. Knecht
Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphoma
Ann Oncol 1999 10: 231-234. [Abstract] [PDF] [Request Permissions]  

Short reports Back

E.-H. Tan, K. S. Khoo, J. Wee, K. W. Fong, K. S. Lee, K. M. Lee, E. T. Chua, T. Tan, H. S. Khoo-Tan, T. L. Yang, E. Au, M. Tao, Y. K. Ong, and E. J. Chua
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
Ann Oncol 1999 10: 235-237. [Abstract] [PDF] [Request Permissions]  

R. Miralbell, S. Bieri, P. Huguenin, A. Feldges, A. M. Morin, E. Garcia, H. P. Wagner, P. Wacker, N. von der Weid, and Swiss Pediatric Oncology Group
Prognostic value of cerebrospinal fluid cytology in pediatric medulloblastoma
Ann Oncol 1999 10: 239-241. [Abstract] [PDF] [Request Permissions]  

Letters to the editor Back

Z. Erjavec, C. E. M. Hollak, and E. G. E. de Vries
Hepatocellular carcinoma in a patient with Gaucher disease on enzyme supplementation therapy
Ann Oncol 1999 10: 243. [PDF] [Request Permissions]  

J.-B. Wasserfallen, P. Rollier, S. Leyvraz, and L. Perey
Cost comparison between PAV and ICE treatment with peripheral blood progenitor cells (PBPC) reinfusion in small-cell lung cancer (SCLC)
Ann Oncol 1999 10: 243-244. [PDF] [Request Permissions]  

V. Lapierre, A. Aupérin, E. Benhamou, and T. Tursz
A specific approval procedure for prescribing albumin: Impact on consumption in a cancer treatment institution
Ann Oncol 1999 10: 244-245. [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.